Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research February 3, 2021
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission February 2, 2021
Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy January 26, 2021
Harmine inhibits the proliferation and migration of glioblastoma cells via the FAK/AKT pathway January 26, 2021
Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine January 25, 2021
Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression January 22, 2021
Clinically meaningful changes on depressive symptom measures and patient-reported outcomes in patients with treatment-resistant depression January 22, 2021
Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants January 20, 2021
Classical Psychedelics as Therapeutics in Psychiatry – Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders January 20, 2021
